Shattuck Labs trades under the ticker symbol STTK on the NASDAQ exchange and exhibits a high degree of volatility typical of clinical-stage biotechnology and pharmaceutical equities. Because its market valuation depends heavily on clinical trial outcomes, regulatory milestones, and periodic research data readouts rather than stable immediate product revenues, the share price frequently experiences sharp intraday fluctuations and dramatic shifts in response to sector-wide sentiment.